accountA newly published study found that more than one-fourth of rheumatoid arthritis patients developed resistance to Abbott Laboratories's blockbuster anti-inflammatory drug Humira, reducing its effectiveness among these patients. Dutch researchers conducted...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Study Finds Some Resistance to Abbott's Humira
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account